Article Details
Retrieved on: 2022-07-12 13:06:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... to other biological (monoclonal antibody) therapies. For benralizumab, future studies should closely monitor rates of adverse events prompting ...
Article found on: www.cochrane.org
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here